An uncommon opportunity for a private 90-minute session with Dr. Tom Pinkson, a pioneering psychedelic researcher, psychologist, author, and longtime student of ancient wisdom traditions.
For more than 55 years, Dr. Pinkson has worked at the intersection of psychology, spiritual inquiry, indigenous knowledge, and personal transformation. His path has included early research at UC Berkeley, international fieldwork from the Amazon to Southeast Asia, and an 11-year apprenticeship with Guadalupe de la Cruz, a respected Huichol mara’akame who recognized in him a bridge between traditional wisdom and the modern world.
This one-on-one session may be shaped around a life transition, a meaningful question, a desire for guidance, or simply the rare chance to sit in conversation with a teacher who has spent a lifetime helping others return to what he describes as “the truth of who and what we are.” The session will take place via Zoom, or in person for winners in the greater Santa Barbara area.
The winning bidder will also receive a signed copy of Dr. Pinkson’s newest book, Psychedelic Shaman: A Wisdom Warrior’s Path to Transformation.
Proceeds from this lot support My Type, an independent narrative feature film inspired by the Type 1 Diabetes diagnosis of Dr. Pinkson’s daughter, Nicole Pinkson. The project carries a dual mission of cinematic storytelling and meaningful awareness for the Type 1 Diabetes community.
As Jeremy Jones, founder of Jones Snowboards and Protect Our Winters, has said: “Tom is an authentic wisdom elder, reminding leaders to stay connected to nature and follow a heart path to success.”
What's included:
Proceeds from this lot support My Type, an independent narrative feature film inspired by the Type 1 Diabetes diagnosis of Nicole MacNaughton, with a mission to pair compelling storytelling with meaningful awareness for the Type 1 Diabetes community.
Notice of Updated Buyer Terms of Use
We have recently updated our Buyer Terms of Use. We encourage you to review the revised terms to ensure continued understanding and compliance. By continuing to use our platform, you acknowledge and agree to the updated terms. View the updated Terms of Use